Prevalence of HER2 overexpression and amplification in cervical cancer: A systematic review and meta-analysis.
The reported rates of HER2 positivity in cervical cancer (CC) range from 0% to 87%. The importance of HER2 as an actionable target in CC would depend on HER2 positivity prevalence. Our aim was to provide precise estimates of HER2 overexpression and amplification in CC, globally and by relevant subgr...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Public Library of Science (PLoS)
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/ab8ebf92343e4ebdb6a4668c08a9319c |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|